Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Barrett Esophagus 13Esophageal Neoplasms 7Rectal Neoplasms 6Colorectal Neoplasms 6Adenocarcinoma Of Esophagus 6Nasopharyngeal Carcinoma 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Polyps 3Lung Neoplasms 3Precancerous Conditions 2Pathologic Complete Response 2Hyperplasia 2Gastroesophageal Reflux 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Adenomatous Polyposis Coli 2Adenocarcinoma 2Urogenital Neoplasms 1Upper Tract Urothelial Carcinoma 1Thyroid Neoplasms 1Stomach Ulcer 1Stomach Diseases 1Recurrence 1Polyposis, Gastric 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Metaplasia 1

Interventions

Celecoxib 6Biopsy 5Sulindac 4Specimen Handling 3Eflornithine 3Curcumin 3Ursodeoxycholic Acid 2Surveys and Questionnaires 2Sirolimus 2Sigmoidoscopy 2Gastroscopy 2Erythromycin 2Erlotinib Hydrochloride 2Endoscopy, Gastrointestinal 2Endoscopy 2Colonoscopy 2trifluridine tipiracil drug combination 1rofecoxib 1obeticholic acid 1guselkumab 1Thiamine 1Suppositories 1Probiotics 1Polymorphism, Single-Stranded Conformational 1Polymerase Chain Reaction 1Pharmaceutical Preparations 1Oxaliplatin 1Nivolumab 1Niclosamide 1Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Adenomatous Polyposis Coli × Endoscopy × Clear all
NCT00510692 2014-08-22

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

S.L.A. Pharma AG

Phase 2/3 Completed
58 enrolled 12 charts
Gastrointestinal

Hyperplasia, Adenomatous Polyposis Coli, Polyps

NCT02162173 2014-06-12

PIVI

King Chulalongkorn Memorial Hospital

Phase NA Completed
26 enrolled
Gastrointestinal

Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon âš¡